Report Cover

Global Animal-derived Immune Globulin Products Market Insights and Forecast to 2026


Animal-derived Immune Globulin Products market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Animal-derived Immune Globulin Products market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the Animal-derived Immune Globulin Products market is segmented into
    IVIg Liquid
    IVIg Powder

Segment by Application, the Animal-derived Immune Globulin Products market is segmented into
    Immunodeficiency
    Autoimmune Disease
    Acute Infection

Regional and Country-level Analysis
The Animal-derived Immune Globulin Products market is analysed and market size information is provided by regions (countries).
The key regions covered in the Animal-derived Immune Globulin Products market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Animal-derived Immune Globulin Products Market Share Analysis
Animal-derived Immune Globulin Products market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Animal-derived Immune Globulin Products business, the date to enter into the Animal-derived Immune Globulin Products market, Animal-derived Immune Globulin Products product introduction, recent developments, etc.

The major vendors covered:
    Pfizer
    Rare Disease Therapeutics
    Instituto Bioclon
    Merck & Co
    Sanofi
    Protherics
    Genzyme Corporation
    ...
1 Study Coverage
    1.1 Animal-derived Immune Globulin Products Product Introduction
    1.2 Market Segments
    1.3 Key Animal-derived Immune Globulin Products Manufacturers Covered: Ranking by Revenue
    1.4 Market by Type
        1.4.1 Global Animal-derived Immune Globulin Products Market Size Growth Rate by Type
        1.4.2 IVIg Liquid
        1.4.3 IVIg Powder
    1.5 Market by Application
        1.5.1 Global Animal-derived Immune Globulin Products Market Size Growth Rate by Application
        1.5.2 Immunodeficiency
        1.5.3 Autoimmune Disease
        1.5.4 Acute Infection
    1.6 Study Objectives
    1.7 Years Considered

2 Executive Summary
    2.1 Global Animal-derived Immune Globulin Products Market Size, Estimates and Forecasts
        2.1.1 Global Animal-derived Immune Globulin Products Revenue 2015-2026
        2.1.2 Global Animal-derived Immune Globulin Products Sales 2015-2026
    2.2 Global Animal-derived Immune Globulin Products, Market Size by Producing Regions: 2015 VS 2020 VS 2026
        2.2.1 Global Animal-derived Immune Globulin Products Retrospective Market Scenario in Sales by Region: 2015-2020
        2.2.2 Global Animal-derived Immune Globulin Products Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global Animal-derived Immune Globulin Products Competitor Landscape by Players
    3.1 Animal-derived Immune Globulin Products Sales by Manufacturers
        3.1.1 Animal-derived Immune Globulin Products Sales by Manufacturers (2015-2020)
        3.1.2 Animal-derived Immune Globulin Products Sales Market Share by Manufacturers (2015-2020)
    3.2 Animal-derived Immune Globulin Products Revenue by Manufacturers
        3.2.1 Animal-derived Immune Globulin Products Revenue by Manufacturers (2015-2020)
        3.2.2 Animal-derived Immune Globulin Products Revenue Share by Manufacturers (2015-2020)
        3.2.3 Global Animal-derived Immune Globulin Products Market Concentration Ratio (CR5 and HHI) (2015-2020)
        3.2.4 Global Top 10 and Top 5 Companies by Animal-derived Immune Globulin Products Revenue in 2019
        3.2.5 Global Animal-derived Immune Globulin Products Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    3.3 Animal-derived Immune Globulin Products Price by Manufacturers
    3.4 Animal-derived Immune Globulin Products Manufacturing Base Distribution, Product Types
        3.4.1 Animal-derived Immune Globulin Products Manufacturers Manufacturing Base Distribution, Headquarters
        3.4.2 Manufacturers Animal-derived Immune Globulin Products Product Type
        3.4.3 Date of International Manufacturers Enter into Animal-derived Immune Globulin Products Market
    3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
    4.1 Global Animal-derived Immune Globulin Products Market Size by Type (2015-2020)
        4.1.1 Global Animal-derived Immune Globulin Products Sales by Type (2015-2020)
        4.1.2 Global Animal-derived Immune Globulin Products Revenue by Type (2015-2020)
        4.1.3 Animal-derived Immune Globulin Products Average Selling Price (ASP) by Type (2015-2026)
    4.2 Global Animal-derived Immune Globulin Products Market Size Forecast by Type (2021-2026)
        4.2.1 Global Animal-derived Immune Globulin Products Sales Forecast by Type (2021-2026)
        4.2.2 Global Animal-derived Immune Globulin Products Revenue Forecast by Type (2021-2026)
        4.2.3 Animal-derived Immune Globulin Products Average Selling Price (ASP) Forecast by Type (2021-2026)
    4.3 Global Animal-derived Immune Globulin Products Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)
    5.1 Global Animal-derived Immune Globulin Products Market Size by Application (2015-2020)
        5.1.1 Global Animal-derived Immune Globulin Products Sales by Application (2015-2020)
        5.1.2 Global Animal-derived Immune Globulin Products Revenue by Application (2015-2020)
        5.1.3 Animal-derived Immune Globulin Products Price by Application (2015-2020)
    5.2 Animal-derived Immune Globulin Products Market Size Forecast by Application (2021-2026)
        5.2.1 Global Animal-derived Immune Globulin Products Sales Forecast by Application (2021-2026)
        5.2.2 Global Animal-derived Immune Globulin Products Revenue Forecast by Application (2021-2026)
        5.2.3 Global Animal-derived Immune Globulin Products Price Forecast by Application (2021-2026)

6 North America
    6.1 North America Animal-derived Immune Globulin Products by Country
        6.1.1 North America Animal-derived Immune Globulin Products Sales by Country
        6.1.2 North America Animal-derived Immune Globulin Products Revenue by Country
        6.1.3 U.S.
        6.1.4 Canada
    6.2 North America Animal-derived Immune Globulin Products Market Facts & Figures by Type
    6.3 North America Animal-derived Immune Globulin Products Market Facts & Figures by Application

7 Europe
    7.1 Europe Animal-derived Immune Globulin Products by Country
        7.1.1 Europe Animal-derived Immune Globulin Products Sales by Country
        7.1.2 Europe Animal-derived Immune Globulin Products Revenue by Country
        7.1.3 Germany
        7.1.4 France
        7.1.5 U.K.
        7.1.6 Italy
        7.1.7 Russia
    7.2 Europe Animal-derived Immune Globulin Products Market Facts & Figures by Type
    7.3 Europe Animal-derived Immune Globulin Products Market Facts & Figures by Application

8 Asia Pacific
    8.1 Asia Pacific Animal-derived Immune Globulin Products by Region
        8.1.1 Asia Pacific Animal-derived Immune Globulin Products Sales by Region
        8.1.2 Asia Pacific Animal-derived Immune Globulin Products Revenue by Region
        8.1.3 China
        8.1.4 Japan
        8.1.5 South Korea
        8.1.6 India
        8.1.7 Australia
        8.1.8 Taiwan
        8.1.9 Indonesia
        8.1.10 Thailand
        8.1.11 Malaysia
        8.1.12 Philippines
        8.1.13 Vietnam
    8.2 Asia Pacific Animal-derived Immune Globulin Products Market Facts & Figures by Type
    8.3 Asia Pacific Animal-derived Immune Globulin Products Market Facts & Figures by Application

9 Latin America
    9.1 Latin America Animal-derived Immune Globulin Products by Country
        9.1.1 Latin America Animal-derived Immune Globulin Products Sales by Country
        9.1.2 Latin America Animal-derived Immune Globulin Products Revenue by Country
        9.1.3 Mexico
        9.1.4 Brazil
        9.1.5 Argentina
    9.2 Central & South America Animal-derived Immune Globulin Products Market Facts & Figures by Type
    9.3 Central & South America Animal-derived Immune Globulin Products Market Facts & Figures by Application

10 Middle East and Africa
    10.1 Middle East and Africa Animal-derived Immune Globulin Products by Country
        10.1.1 Middle East and Africa Animal-derived Immune Globulin Products Sales by Country
        10.1.2 Middle East and Africa Animal-derived Immune Globulin Products Revenue by Country
        10.1.3 Turkey
        10.1.4 Saudi Arabia
        10.1.5 U.A.E
    10.2 Middle East and Africa Animal-derived Immune Globulin Products Market Facts & Figures by Type
    10.3 Middle East and Africa Animal-derived Immune Globulin Products Market Facts & Figures by Application

11 Company Profiles
    11.1 Pfizer
        11.1.1 Pfizer Corporation Information
        11.1.2 Pfizer Description and Business Overview
        11.1.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
        11.1.4 Pfizer Animal-derived Immune Globulin Products Products Offered
        11.1.5 Pfizer Related Developments
    11.2 Rare Disease Therapeutics
        11.2.1 Rare Disease Therapeutics Corporation Information
        11.2.2 Rare Disease Therapeutics Description and Business Overview
        11.2.3 Rare Disease Therapeutics Sales, Revenue and Gross Margin (2015-2020)
        11.2.4 Rare Disease Therapeutics Animal-derived Immune Globulin Products Products Offered
        11.2.5 Rare Disease Therapeutics Related Developments
    11.3 Instituto Bioclon
        11.3.1 Instituto Bioclon Corporation Information
        11.3.2 Instituto Bioclon Description and Business Overview
        11.3.3 Instituto Bioclon Sales, Revenue and Gross Margin (2015-2020)
        11.3.4 Instituto Bioclon Animal-derived Immune Globulin Products Products Offered
        11.3.5 Instituto Bioclon Related Developments
    11.4 Merck & Co
        11.4.1 Merck & Co Corporation Information
        11.4.2 Merck & Co Description and Business Overview
        11.4.3 Merck & Co Sales, Revenue and Gross Margin (2015-2020)
        11.4.4 Merck & Co Animal-derived Immune Globulin Products Products Offered
        11.4.5 Merck & Co Related Developments
    11.5 Sanofi
        11.5.1 Sanofi Corporation Information
        11.5.2 Sanofi Description and Business Overview
        11.5.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
        11.5.4 Sanofi Animal-derived Immune Globulin Products Products Offered
        11.5.5 Sanofi Related Developments
    11.6 Protherics
        11.6.1 Protherics Corporation Information
        11.6.2 Protherics Description and Business Overview
        11.6.3 Protherics Sales, Revenue and Gross Margin (2015-2020)
        11.6.4 Protherics Animal-derived Immune Globulin Products Products Offered
        11.6.5 Protherics Related Developments
    11.7 Genzyme Corporation
        11.7.1 Genzyme Corporation Corporation Information
        11.7.2 Genzyme Corporation Description and Business Overview
        11.7.3 Genzyme Corporation Sales, Revenue and Gross Margin (2015-2020)
        11.7.4 Genzyme Corporation Animal-derived Immune Globulin Products Products Offered
        11.7.5 Genzyme Corporation Related Developments
    11.1 Pfizer
        11.1.1 Pfizer Corporation Information
        11.1.2 Pfizer Description and Business Overview
        11.1.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
        11.1.4 Pfizer Animal-derived Immune Globulin Products Products Offered
        11.1.5 Pfizer Related Developments

12 Future Forecast by Regions (Countries) (2021-2026)
    12.1 Animal-derived Immune Globulin Products Market Estimates and Projections by Region
        12.1.1 Global Animal-derived Immune Globulin Products Sales Forecast by Regions 2021-2026
        12.1.2 Global Animal-derived Immune Globulin Products Revenue Forecast by Regions 2021-2026
    12.2 North America Animal-derived Immune Globulin Products Market Size Forecast (2021-2026)
        12.2.1 North America: Animal-derived Immune Globulin Products Sales Forecast (2021-2026)
        12.2.2 North America: Animal-derived Immune Globulin Products Revenue Forecast (2021-2026)
        12.2.3 North America: Animal-derived Immune Globulin Products Market Size Forecast by Country (2021-2026)
    12.3 Europe Animal-derived Immune Globulin Products Market Size Forecast (2021-2026)
        12.3.1 Europe: Animal-derived Immune Globulin Products Sales Forecast (2021-2026)
        12.3.2 Europe: Animal-derived Immune Globulin Products Revenue Forecast (2021-2026)
        12.3.3 Europe: Animal-derived Immune Globulin Products Market Size Forecast by Country (2021-2026)
    12.4 Asia Pacific Animal-derived Immune Globulin Products Market Size Forecast (2021-2026)
        12.4.1 Asia Pacific: Animal-derived Immune Globulin Products Sales Forecast (2021-2026)
        12.4.2 Asia Pacific: Animal-derived Immune Globulin Products Revenue Forecast (2021-2026)
        12.4.3 Asia Pacific: Animal-derived Immune Globulin Products Market Size Forecast by Region (2021-2026)
    12.5 Latin America Animal-derived Immune Globulin Products Market Size Forecast (2021-2026)
        12.5.1 Latin America: Animal-derived Immune Globulin Products Sales Forecast (2021-2026)
        12.5.2 Latin America: Animal-derived Immune Globulin Products Revenue Forecast (2021-2026)
        12.5.3 Latin America: Animal-derived Immune Globulin Products Market Size Forecast by Country (2021-2026)
    12.6 Middle East and Africa Animal-derived Immune Globulin Products Market Size Forecast (2021-2026)
        12.6.1 Middle East and Africa: Animal-derived Immune Globulin Products Sales Forecast (2021-2026)
        12.6.2 Middle East and Africa: Animal-derived Immune Globulin Products Revenue Forecast (2021-2026)
        12.6.3 Middle East and Africa: Animal-derived Immune Globulin Products Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
    13.1 Market Opportunities and Drivers
    13.2 Market Challenges
    13.3 Market Risks/Restraints
    13.4 Porter's Five Forces Analysis
    13.5 Primary Interviews with Key Animal-derived Immune Globulin Products Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis
    14.1 Value Chain Analysis
    14.2 Animal-derived Immune Globulin Products Customers
    14.3 Sales Channels Analysis
        14.3.1 Sales Channels
        14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
    16.1 Research Methodology
        16.1.1 Methodology/Research Approach
        16.1.2 Data Source
    16.2 Author Details
    16.3 Disclaimer

List of Tables Table 1. Animal-derived Immune Globulin Products Market Segments Table 2. Ranking of Global Top Animal-derived Immune Globulin Products Manufacturers by Revenue (US$ Million) in 2019 Table 3. Global Animal-derived Immune Globulin Products Market Size Growth Rate by Type 2020-2026 (MT) & (US$ Million) Table 4. Major Manufacturers of IVIg Liquid Table 5. Major Manufacturers of IVIg Powder Table 6. Global Animal-derived Immune Globulin Products Market Size Growth Rate by Application 2020-2026 (MT) Table 7. Global Animal-derived Immune Globulin Products Market Size by Region (MT) & (US$ Million): 2020 VS 2026 Table 8. Global Animal-derived Immune Globulin Products Sales by Regions 2015-2020 (MT) Table 9. Global Animal-derived Immune Globulin Products Sales Market Share by Regions (2015-2020) Table 10. Global Animal-derived Immune Globulin Products Revenue by Regions 2015-2020 (US$ Million) Table 11. Global Animal-derived Immune Globulin Products Sales by Manufacturers (2015-2020) (MT) Table 12. Global Animal-derived Immune Globulin Products Sales Share by Manufacturers (2015-2020) Table 13. Global Animal-derived Immune Globulin Products Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020) Table 14. Global Animal-derived Immune Globulin Products by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Animal-derived Immune Globulin Products as of 2019) Table 15. Animal-derived Immune Globulin Products Revenue by Manufacturers (2015-2020) (US$ Million) Table 16. Animal-derived Immune Globulin Products Revenue Share by Manufacturers (2015-2020) Table 17. Key Manufacturers Animal-derived Immune Globulin Products Price (2015-2020) (USD/Kg) Table 18. Animal-derived Immune Globulin Products Manufacturers Manufacturing Base Distribution and Headquarters Table 19. Manufacturers Animal-derived Immune Globulin Products Product Type Table 20. Date of International Manufacturers Enter into Animal-derived Immune Globulin Products Market Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans Table 22. Global Animal-derived Immune Globulin Products Sales by Type (2015-2020) (MT) Table 23. Global Animal-derived Immune Globulin Products Sales Share by Type (2015-2020) Table 24. Global Animal-derived Immune Globulin Products Revenue by Type (2015-2020) (US$ Million) Table 25. Global Animal-derived Immune Globulin Products Revenue Share by Type (2015-2020) Table 26. Animal-derived Immune Globulin Products Average Selling Price (ASP) by Type 2015-2020 (USD/Kg) Table 27. Global Animal-derived Immune Globulin Products Sales by Application (2015-2020) (MT) Table 28. Global Animal-derived Immune Globulin Products Sales Share by Application (2015-2020) Table 29. North America Animal-derived Immune Globulin Products Sales by Country (2015-2020) (MT) Table 30. North America Animal-derived Immune Globulin Products Sales Market Share by Country (2015-2020) Table 31. North America Animal-derived Immune Globulin Products Revenue by Country (2015-2020) (US$ Million) Table 32. North America Animal-derived Immune Globulin Products Revenue Market Share by Country (2015-2020) Table 33. North America Animal-derived Immune Globulin Products Sales by Type (2015-2020) (MT) Table 34. North America Animal-derived Immune Globulin Products Sales Market Share by Type (2015-2020) Table 35. North America Animal-derived Immune Globulin Products Sales by Application (2015-2020) (MT) Table 36. North America Animal-derived Immune Globulin Products Sales Market Share by Application (2015-2020) Table 37. Europe Animal-derived Immune Globulin Products Sales by Country (2015-2020) (MT) Table 38. Europe Animal-derived Immune Globulin Products Sales Market Share by Country (2015-2020) Table 39. Europe Animal-derived Immune Globulin Products Revenue by Country (2015-2020) (US$ Million) Table 40. Europe Animal-derived Immune Globulin Products Revenue Market Share by Country (2015-2020) Table 41. Europe Animal-derived Immune Globulin Products Sales by Type (2015-2020) (MT) Table 42. Europe Animal-derived Immune Globulin Products Sales Market Share by Type (2015-2020) Table 43. Europe Animal-derived Immune Globulin Products Sales by Application (2015-2020) (MT) Table 44. Europe Animal-derived Immune Globulin Products Sales Market Share by Application (2015-2020) Table 45. Asia Pacific Animal-derived Immune Globulin Products Sales by Region (2015-2020) (MT) Table 46. Asia Pacific Animal-derived Immune Globulin Products Sales Market Share by Region (2015-2020) Table 47. Asia Pacific Animal-derived Immune Globulin Products Revenue by Region (2015-2020) (US$ Million) Table 48. Asia Pacific Animal-derived Immune Globulin Products Revenue Market Share by Region (2015-2020) Table 49. Asia Pacific Animal-derived Immune Globulin Products Sales by Type (2015-2020) (MT) Table 50. Asia Pacific Animal-derived Immune Globulin Products Sales Market Share by Type (2015-2020) Table 51. Asia Pacific Animal-derived Immune Globulin Products Sales by Application (2015-2020) (MT) Table 52. Asia Pacific Animal-derived Immune Globulin Products Sales Market Share by Application (2015-2020) Table 53. Latin America Animal-derived Immune Globulin Products Sales by Country (2015-2020) (MT) Table 54. Latin America Animal-derived Immune Globulin Products Sales Market Share by Country (2015-2020) Table 55. Latin Americaa Animal-derived Immune Globulin Products Revenue by Country (2015-2020) (US$ Million) Table 56. Latin America Animal-derived Immune Globulin Products Revenue Market Share by Country (2015-2020) Table 57. Latin America Animal-derived Immune Globulin Products Sales by Type (2015-2020) (MT) Table 58. Latin America Animal-derived Immune Globulin Products Sales Market Share by Type (2015-2020) Table 59. Latin America Animal-derived Immune Globulin Products Sales by Application (2015-2020) (MT) Table 60. Latin America Animal-derived Immune Globulin Products Sales Market Share by Application (2015-2020) Table 61. Middle East and Africa Animal-derived Immune Globulin Products Sales by Country (2015-2020) (MT) Table 62. Middle East and Africa Animal-derived Immune Globulin Products Sales Market Share by Country (2015-2020) Table 63. Middle East and Africa Animal-derived Immune Globulin Products Revenue by Country (2015-2020) (US$ Million) Table 64. Middle East and Africa Animal-derived Immune Globulin Products Revenue Market Share by Country (2015-2020) Table 65. Middle East and Africa Animal-derived Immune Globulin Products Sales by Type (2015-2020) (MT) Table 66. Middle East and Africa Animal-derived Immune Globulin Products Sales Market Share by Type (2015-2020) Table 67. Middle East and Africa Animal-derived Immune Globulin Products Sales by Application (2015-2020) (MT) Table 68. Middle East and Africa Animal-derived Immune Globulin Products Sales Market Share by Application (2015-2020) Table 69. Pfizer Corporation Information Table 70. Pfizer Description and Major Businesses Table 71. Pfizer Animal-derived Immune Globulin Products Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020) Table 72. Pfizer Product Table 73. Pfizer Recent Development Table 74. Rare Disease Therapeutics Corporation Information Table 75. Rare Disease Therapeutics Description and Major Businesses Table 76. Rare Disease Therapeutics Animal-derived Immune Globulin Products Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020) Table 77. Rare Disease Therapeutics Product Table 78. Rare Disease Therapeutics Recent Development Table 79. Instituto Bioclon Corporation Information Table 80. Instituto Bioclon Description and Major Businesses Table 81. Instituto Bioclon Animal-derived Immune Globulin Products Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020) Table 82. Instituto Bioclon Product Table 83. Instituto Bioclon Recent Development Table 84. Merck & Co Corporation Information Table 85. Merck & Co Description and Major Businesses Table 86. Merck & Co Animal-derived Immune Globulin Products Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020) Table 87. Merck & Co Product Table 88. Merck & Co Recent Development Table 89. Sanofi Corporation Information Table 90. Sanofi Description and Major Businesses Table 91. Sanofi Animal-derived Immune Globulin Products Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020) Table 92. Sanofi Product Table 93. Sanofi Recent Development Table 94. Protherics Corporation Information Table 95. Protherics Description and Major Businesses Table 96. Protherics Animal-derived Immune Globulin Products Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020) Table 97. Protherics Product Table 98. Protherics Recent Development Table 99. Genzyme Corporation Corporation Information Table 100. Genzyme Corporation Description and Major Businesses Table 101. Genzyme Corporation Animal-derived Immune Globulin Products Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020) Table 102. Genzyme Corporation Product Table 103. Genzyme Corporation Recent Development Table 104. Global Animal-derived Immune Globulin Products Sales Forecast by Regions (2021-2026) (MT) Table 105. Global Animal-derived Immune Globulin Products Sales Market Share Forecast by Regions (2021-2026) Table 106. Global Animal-derived Immune Globulin Products Revenue Forecast by Regions (2021-2026) (US$ Million) Table 107. Global Animal-derived Immune Globulin Products Revenue Market Share Forecast by Regions (2021-2026) Table 108. North America: Animal-derived Immune Globulin Products Sales Forecast by Country (2021-2026) (MT) Table 109. North America: Animal-derived Immune Globulin Products Revenue Forecast by Country (2021-2026) (US$ Million) Table 110. Europe: Animal-derived Immune Globulin Products Sales Forecast by Country (2021-2026) (MT) Table 111. Europe: Animal-derived Immune Globulin Products Revenue Forecast by Country (2021-2026) (US$ Million) Table 112. Asia Pacific: Animal-derived Immune Globulin Products Sales Forecast by Region (2021-2026) (MT) Table 113. Asia Pacific: Animal-derived Immune Globulin Products Revenue Forecast by Region (2021-2026) (US$ Million) Table 114. Latin America: Animal-derived Immune Globulin Products Sales Forecast by Country (2021-2026) (MT) Table 115. Latin America: Animal-derived Immune Globulin Products Revenue Forecast by Country (2021-2026) (US$ Million) Table 116. Middle East and Africa: Animal-derived Immune Globulin Products Sales Forecast by Country (2021-2026) (MT) Table 117. Middle East and Africa: Animal-derived Immune Globulin Products Revenue Forecast by Country (2021-2026) (US$ Million) Table 118. Key Opportunities and Drivers: Impact Analysis (2021-2026) Table 119. Key Challenges Table 120. Market Risks Table 121. Main Points Interviewed from Key Animal-derived Immune Globulin Products Players Table 122. Animal-derived Immune Globulin Products Customers List Table 123. Animal-derived Immune Globulin Products Distributors List Table 124. Research Programs/Design for This Report Table 125. Key Data Information from Secondary Sources Table 126. Key Data Information from Primary Sources List of Figures Figure 1. Animal-derived Immune Globulin Products Product Picture Figure 2. Global Animal-derived Immune Globulin Products Sales Market Share by Type in 2020 & 2026 Figure 3. IVIg Liquid Product Picture Figure 4. IVIg Powder Product Picture Figure 5. Global Animal-derived Immune Globulin Products Sales Market Share by Application in 2020 & 2026 Figure 6. Immunodeficiency Figure 7. Autoimmune Disease Figure 8. Acute Infection Figure 9. Animal-derived Immune Globulin Products Report Years Considered Figure 10. Global Animal-derived Immune Globulin Products Market Size 2015-2026 (US$ Million) Figure 11. Global Animal-derived Immune Globulin Products Sales 2015-2026 (MT) Figure 12. Global Animal-derived Immune Globulin Products Market Size Market Share by Region: 2020 Versus 2026 Figure 13. Global Animal-derived Immune Globulin Products Sales Market Share by Region (2015-2020) Figure 14. Global Animal-derived Immune Globulin Products Sales Market Share by Region in 2019 Figure 15. Global Animal-derived Immune Globulin Products Revenue Market Share by Region (2015-2020) Figure 16. Global Animal-derived Immune Globulin Products Revenue Market Share by Region in 2019 Figure 17. Global Animal-derived Immune Globulin Products Sales Share by Manufacturer in 2019 Figure 18. The Top 10 and 5 Players Market Share by Animal-derived Immune Globulin Products Revenue in 2019 Figure 19. Animal-derived Immune Globulin Products Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019 Figure 20. Global Animal-derived Immune Globulin Products Sales Market Share by Type (2015-2020) Figure 21. Global Animal-derived Immune Globulin Products Sales Market Share by Type in 2019 Figure 22. Global Animal-derived Immune Globulin Products Revenue Market Share by Type (2015-2020) Figure 23. Global Animal-derived Immune Globulin Products Revenue Market Share by Type in 2019 Figure 24. Global Animal-derived Immune Globulin Products Market Share by Price Range (2015-2020) Figure 25. Global Animal-derived Immune Globulin Products Sales Market Share by Application (2015-2020) Figure 26. Global Animal-derived Immune Globulin Products Sales Market Share by Application in 2019 Figure 27. Global Animal-derived Immune Globulin Products Revenue Market Share by Application (2015-2020) Figure 28. Global Animal-derived Immune Globulin Products Revenue Market Share by Application in 2019 Figure 29. North America Animal-derived Immune Globulin Products Sales Growth Rate 2015-2020 (MT) Figure 30. North America Animal-derived Immune Globulin Products Revenue Growth Rate 2015-2020 (US$ Million) Figure 31. North America Animal-derived Immune Globulin Products Sales Market Share by Country in 2019 Figure 32. North America Animal-derived Immune Globulin Products Revenue Market Share by Country in 2019 Figure 33. U.S. Animal-derived Immune Globulin Products Sales Growth Rate (2015-2020) (MT) Figure 34. U.S. Animal-derived Immune Globulin Products Revenue Growth Rate (2015-2020) (US$ Million) Figure 35. Canada Animal-derived Immune Globulin Products Sales Growth Rate (2015-2020) (MT) Figure 36. Canada Animal-derived Immune Globulin Products Revenue Growth Rate (2015-2020) (US$ Million) Figure 37. North America Animal-derived Immune Globulin Products Market Share by Type in 2019 Figure 38. North America Animal-derived Immune Globulin Products Market Share by Application in 2019 Figure 39. Europe Animal-derived Immune Globulin Products Sales Growth Rate 2015-2020 (MT) Figure 40. Europe Animal-derived Immune Globulin Products Revenue Growth Rate 2015-2020 (US$ Million) Figure 41. Europe Animal-derived Immune Globulin Products Sales Market Share by Country in 2019 Figure 42. Europe Animal-derived Immune Globulin Products Revenue Market Share by Country in 2019 Figure 43. Germany Animal-derived Immune Globulin Products Sales Growth Rate (2015-2020) (MT) Figure 44. Germany Animal-derived Immune Globulin Products Revenue Growth Rate (2015-2020) (US$ Million) Figure 45. France Animal-derived Immune Globulin Products Sales Growth Rate (2015-2020) (MT) Figure 46. France Animal-derived Immune Globulin Products Revenue Growth Rate (2015-2020) (US$ Million) Figure 47. U.K. Animal-derived Immune Globulin Products Sales Growth Rate (2015-2020) (MT) Figure 48. U.K. Animal-derived Immune Globulin Products Revenue Growth Rate (2015-2020) (US$ Million) Figure 49. Italy Animal-derived Immune Globulin Products Sales Growth Rate (2015-2020) (MT) Figure 50. Italy Animal-derived Immune Globulin Products Revenue Growth Rate (2015-2020) (US$ Million) Figure 51. Russia Animal-derived Immune Globulin Products Sales Growth Rate (2015-2020) (MT) Figure 52. Russia Animal-derived Immune Globulin Products Revenue Growth Rate (2015-2020) (US$ Million) Figure 53. Europe Animal-derived Immune Globulin Products Market Share by Type in 2019 Figure 54. Europe Animal-derived Immune Globulin Products Market Share by Application in 2019 Figure 55. Asia Pacific Animal-derived Immune Globulin Products Sales Growth Rate 2015-2020 (MT) Figure 56. Asia Pacific Animal-derived Immune Globulin Products Revenue Growth Rate 2015-2020 (US$ Million) Figure 57. Asia Pacific Animal-derived Immune Globulin Products Sales Market Share by Region in 2019 Figure 58. Asia Pacific Animal-derived Immune Globulin Products Revenue Market Share by Region in 2019 Figure 59. China Animal-derived Immune Globulin Products Sales Growth Rate (2015-2020) (MT) Figure 60. China Animal-derived Immune Globulin Products Revenue Growth Rate (2015-2020) (US$ Million) Figure 61. Japan Animal-derived Immune Globulin Products Sales Growth Rate (2015-2020) (MT) Figure 62. Japan Animal-derived Immune Globulin Products Revenue Growth Rate (2015-2020) (US$ Million) Figure 63. South Korea Animal-derived Immune Globulin Products Sales Growth Rate (2015-2020) (MT) Figure 64. South Korea Animal-derived Immune Globulin Products Revenue Growth Rate (2015-2020) (US$ Million) Figure 65. India Animal-derived Immune Globulin Products Sales Growth Rate (2015-2020) (MT) Figure 66. India Animal-derived Immune Globulin Products Revenue Growth Rate (2015-2020) (US$ Million) Figure 67. Australia Animal-derived Immune Globulin Products Sales Growth Rate (2015-2020) (MT) Figure 68. Australia Animal-derived Immune Globulin Products Revenue Growth Rate (2015-2020) (US$ Million) Figure 69. Taiwan Animal-derived Immune Globulin Products Sales Growth Rate (2015-2020) (MT) Figure 70. Taiwan Animal-derived Immune Globulin Products Revenue Growth Rate (2015-2020) (US$ Million) Figure 71. Indonesia Animal-derived Immune Globulin Products Sales Growth Rate (2015-2020) (MT) Figure 72. Indonesia Animal-derived Immune Globulin Products Revenue Growth Rate (2015-2020) (US$ Million) Figure 73. Thailand Animal-derived Immune Globulin Products Sales Growth Rate (2015-2020) (MT) Figure 74. Thailand Animal-derived Immune Globulin Products Revenue Growth Rate (2015-2020) (US$ Million) Figure 75. Malaysia Animal-derived Immune Globulin Products Sales Growth Rate (2015-2020) (MT) Figure 76. Malaysia Animal-derived Immune Globulin Products Revenue Growth Rate (2015-2020) (US$ Million) Figure 77. Philippines Animal-derived Immune Globulin Products Sales Growth Rate (2015-2020) (MT) Figure 78. Philippines Animal-derived Immune Globulin Products Revenue Growth Rate (2015-2020) (US$ Million) Figure 79. Vietnam Animal-derived Immune Globulin Products Sales Growth Rate (2015-2020) (MT) Figure 80. Vietnam Animal-derived Immune Globulin Products Revenue Growth Rate (2015-2020) (US$ Million) Figure 81. Asia Pacific Animal-derived Immune Globulin Products Market Share by Type in 2019 Figure 82. Asia Pacific Animal-derived Immune Globulin Products Market Share by Application in 2019 Figure 83. Latin America Animal-derived Immune Globulin Products Sales Growth Rate 2015-2020 (MT) Figure 84. Latin America Animal-derived Immune Globulin Products Revenue Growth Rate 2015-2020 (US$ Million) Figure 85. Latin America Animal-derived Immune Globulin Products Sales Market Share by Country in 2019 Figure 86. Latin America Animal-derived Immune Globulin Products Revenue Market Share by Country in 2019 Figure 87. Mexico Animal-derived Immune Globulin Products Sales Growth Rate (2015-2020) (MT) Figure 88. Mexico Animal-derived Immune Globulin Products Revenue Growth Rate (2015-2020) (US$ Million) Figure 89. Brazil Animal-derived Immune Globulin Products Sales Growth Rate (2015-2020) (MT) Figure 90. Brazil Animal-derived Immune Globulin Products Revenue Growth Rate (2015-2020) (US$ Million) Figure 91. Argentina Animal-derived Immune Globulin Products Sales Growth Rate (2015-2020) (MT) Figure 92. Argentina Animal-derived Immune Globulin Products Revenue Growth Rate (2015-2020) (US$ Million) Figure 93. Latin America Animal-derived Immune Globulin Products Market Share by Type in 2019 Figure 94. Latin America Animal-derived Immune Globulin Products Market Share by Application in 2019 Figure 95. Middle East and Africa Animal-derived Immune Globulin Products Sales Growth Rate 2015-2020 (MT) Figure 96. Middle East and Africa Animal-derived Immune Globulin Products Revenue Growth Rate 2015-2020 (US$ Million) Figure 97. Middle East and Africa Animal-derived Immune Globulin Products Sales Market Share by Country in 2019 Figure 98. Middle East and Africa Animal-derived Immune Globulin Products Revenue Market Share by Country in 2019 Figure 99. Turkey Animal-derived Immune Globulin Products Sales Growth Rate (2015-2020) (MT) Figure 100. Turkey Animal-derived Immune Globulin Products Revenue Growth Rate (2015-2020) (US$ Million) Figure 101. Saudi Arabia Animal-derived Immune Globulin Products Sales Growth Rate (2015-2020) (MT) Figure 102. Saudi Arabia Animal-derived Immune Globulin Products Revenue Growth Rate (2015-2020) (US$ Million) Figure 103. U.A.E Animal-derived Immune Globulin Products Sales Growth Rate (2015-2020) (MT) Figure 104. U.A.E Animal-derived Immune Globulin Products Revenue Growth Rate (2015-2020) (US$ Million) Figure 105. Middle East and Africa Animal-derived Immune Globulin Products Market Share by Type in 2019 Figure 106. Middle East and Africa Animal-derived Immune Globulin Products Market Share by Application in 2019 Figure 107. North America Animal-derived Immune Globulin Products Sales Growth Rate Forecast (2021-2026) (MT) Figure 108. North America Animal-derived Immune Globulin Products Revenue Growth Rate Forecast (2021-2026) (US$ Million) Figure 109. Europe Animal-derived Immune Globulin Products Sales Growth Rate Forecast (2021-2026) (MT) Figure 110. Europe Animal-derived Immune Globulin Products Revenue Growth Rate Forecast (2021-2026) (US$ Million) Figure 111. Asia Pacific Animal-derived Immune Globulin Products Sales Growth Rate Forecast (2021-2026) (MT) Figure 112. Asia Pacific Animal-derived Immune Globulin Products Revenue Growth Rate Forecast (2021-2026) (US$ Million) Figure 113. Latin America Animal-derived Immune Globulin Products Sales Growth Rate Forecast (2021-2026) (MT) Figure 114. Latin America Animal-derived Immune Globulin Products Revenue Growth Rate Forecast (2021-2026) (US$ Million) Figure 115. Middle East and Africa Animal-derived Immune Globulin Products Sales Growth Rate Forecast (2021-2026) (MT) Figure 116. Middle East and Africa Animal-derived Immune Globulin Products Revenue Growth Rate Forecast (2021-2026) (US$ Million) Figure 117. Porter's Five Forces Analysis Figure 118. Channels of Distribution Figure 119. Distributors Profiles Figure 120. Bottom-up and Top-down Approaches for This Report Figure 121. Data Triangulation Figure 122. Key Executives Interviewed

This research study involved the extensive usage of both primary and secondary data sources.  The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. Top-down and bottom-up approaches are used to validate the global market size market and estimate the market size for manufacturers, regions segments, product segments and applications (end users). All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from QYResearch and presented in this report.
 

After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
 

Secondary Sources occupies Approximately 25% of Sources, such as press releases, annual reports, Non-Profit organizations, industry associations, governmental agencies and customs data, and so on; This research study involved the usage of widespread secondary sources; directories; databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), TRADING ECONOMICS, and avention; Investing News Network; statista; Federal Reserve Economic Data; annual reports; BIS Statistics; ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the Light Aircraft market. It was also used to obtain important information about the top players, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
 

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product manufacturers (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers etc.
 

The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end users (product buyers), and related key executives from various key companies and organizations operating in the global market.
 

Primary research was conducted to identify segmentation types, product price range, product applications, key players, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
 

New Pharmaceuticals and Healthcare Reports

Internal Neuromodulation Market Forecast 2025 | Global Report

Rising number of patients suffering from neurological disorders such as Parkinson’s, essential tremor, and primary dystonia is fueling the demand for internal neuromodulation procedures. Chronic back and leg pain associated with PVD (peripheral...

Gastrointestinal Cancer Treatment Market Size 2020-2025 | Growth Forecasts

As per credible projections, gastrointestinal cancer treatment industry is expected to register strong CAGR over 2019-2025. Rising adoption of unhealthy eating habits and increasing consumption of tobacco and alcohol have increased the pervasiveness ...

Topotecan Hydrochloride Market Trends and Research Insights by 2025

As per credible estimates, global topotecan hydrochloride market is poised to acquire commendable gains by the year 2025. Rising adoption of unhealthy and sedentary lifestyle has increased the pervasiveness of small cell lung cancer, ovarian cancer, ...

Flu Vaccine Market Share 2020-2025 | Global Industry Report

As per trusted estimates, global flu vaccine market will record substantial growth during 2020-2025. Increasing government initiatives to ensure the safety of the populace, minimal side-effects associated with influenza vaccines, improving efficacy o...

Healthcare Linen Market Size - Industry Trends Report 2025

According to reliable projections, global healthcare linen market is projected to record considerable growth during 2020-2025. Rising prevalence of various diseases including cardiovascular diseases, cancer, and arthritis along with increasing cases ...

Other Reports by QY Research

Global and Japan Anti-Migraine Drugs Market Insights, Forecast to 2026

Anti-Migraine Drugs market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Anti-Migraine Drugs market will be able to gain the upper hand as they use the report as a ...

Global and Japan Hyperlipidemia Prescription Drugs Market Insights, Forecast to 2026

Hyperlipidemia Prescription Drugs market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Hyperlipidemia Prescription Drugs market will be able to gain the upper hand ...

Global and China Anti-Hypertensive Drugs Market Insights, Forecast to 2026

Anti-Hypertensive Drugs market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Anti-Hypertensive Drugs market will be able to gain the upper hand as they use the repo...

Global and United States Gaucher Disease Drugs Market Insights, Forecast to 2026

Gaucher Disease Drugs market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Gaucher Disease Drugs market will be able to gain the upper hand as they use the report a...

Global and China Ubiquitin Proteasome Market Size, Status and Forecast 2020-2026

Global Ubiquitin Proteasome Scope and Market Size Ubiquitin Proteasome market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Ubiquitin Proteasome market will be able to gain the upper hand as th...

Publisher: QY Research
Chat with us